As a subsidiary of Baxter International Inc., Baxter Corporation manufactures and markets products that save and sustain the lives of people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma and other chronic and acute medical conditions. As a global, diversified healthcare company, Baxter applies a unique combination of expertise in medical devices, pharmaceuticals and biotechnology to create products that advance patient care worldwide.
In 1937, Baxter expanded into Canada as the company’s first international location outside the United States. Seven employees, working out of a rented building in Toronto, produced intravenous solutions in glass bottles.
Today, approximately 1,150 Baxter employees work to make a meaningful difference in the lives of Canadian patients from manufacturing facilities in Alliston, Ontario and Sherbrooke, Quebec; and in Mississauga, Ontario, from its Baxter CIVA Pharmacy Services, Canadian Technical Services and Canadian headquarters.
Baxter's BioScience business is a leader in recombinant and plasma-based protein replacement therapies to treat hemophilia and other bleeding disorders; plasma-based therapies to treat immune deficiencies, burns and shock, and other rare blood-related conditions; products for regenerative medicine such as biosurgery wound healing products; and vaccines.
The Medication Delivery business is a leading manufacturer of products used in the delivery of fluids and drugs to patients. These include intravenous (IV) solutions and needleless administration sets, premixed drugs and drug-reconstitution systems, nutrition products, oncolytics, DERS enabled infusion pumps, and inhaled anesthetics. All products help customers mitigate healthcare acquired infections and medication errors.
The Renal business is a leader in home-based dialysis therapies for patients living with end-stage renal disease, or irreversible kidney failure. It is a manufacturer of products for peritoneal dialysis (PD), a home therapy Baxter introduced 30 years ago, including PD solutions automated cyclers and clinical software. The business also manufactures and distributes products for hemodialysis (HD), a therapy that generally takes place in a hospital or clinic.
In 1940, Baxter established its first Canadian manufacturing facility in Acton, Ontario. In 1957, the facility moved to Alliston, Ontario. More than fifty years later, Baxter’s Alliston facility continues to manufacture products that help save and improve patients’ lives.
The 180,000-square-foot plant, which currently employs more than 400 people, manufactures life-sustaining intravenous (IV), nutritional, peritoneal dialysis and hemodialysis solutions - 99 percent of which are sold in Canada. Baxter’s Alliston facility is the longest standing parenteral solutions plant in Canada and the only Canadian manufacturer of peritoneal dialysis solutions.
In 1983, Baxter established its second Canadian manufacturing facility in Sherbrooke, Quebec. The 35,000-square-foot facility, which currently employs more than 130 people, produces medical sets for the IV administration of medications and solutions – 100 percent of which are sold in Canada. In 2005, Baxter’s Sherbrooke facility became Canada’s first manufacturing facility to receive Carbon Neutral Certification.
In 1986, Baxter opened Canada’s first out-of-hospital admixture facility. Featuring state-of-the-art quality control processes and clean room technology, Baxter’s Central Intravenous Admixture (CIVA) pharmacy service provides Canadian hospital pharmacists and healthcare professionals with sterile parenteral therapies in a wide array of compounded formulations with extended shelf-life. Baxter’s CIVA Pharmacy Services provides a range of IV therapies encompassing oncology, anti-infectives, analgesics, parenteral nutrition, critical care areas and cardioplegic solutions.
Baxter provides customers with comprehensive post-sales equipment support through its Canadian Technical Services depot. The 11,500-square-foot facility, located in Mississauga, Ontario, assists Canadian hospital customers, healthcare professionals and home patients with field and depot service repairs, technical training, service contract management, parts ordering and distribution, and Baxter’s Renal SWAP Program. Through Canadian Technical Services, Baxter works to ensure customer satisfaction by delivering ease of ordering, consistent parts availability, reliable service response turnaround times, prompt response to technical support requests and comprehensive technical training on Baxter devices.
Baxter genuinely believes in being a global citizen with local impact. Whether through monetary or product donations, or through volunteerism, Baxter is committed to making a positive impact on the health and well-being of its local and global communities. Baxter's charitable giving activities align with and support the company's mission of saving and sustaining lives.
In 2009, Baxter donated products to Health Partners International of Canada, a not-for-profit relief and development organization in support of their mission to increase access to medicine and improve health in the developing world. Recent initiatives also include supporting disaster relief efforts in Haiti by Canadian Red Cross and Doctors Without Borders/ Médecins Sans Frontières.
Grants totaling $141,218 USD were also provided in 2009 by The Baxter International Foundation to Canadian community organizations:
• Best Start Health Coalition of Peel - $27,650
• Canadian Mental Health Association of Simcoe County - $40,300
• Cedarbrook Society (Darling Home for Kids) - $22,570
• CONTACT: KICK (Kids in the Community Kitchen) After School and Summer Program - $50,700
Baxter is actively engaged in the community and participates in a number of charitable activities throughout the year in support of local, provincial and national events. In 2009, Baxter employees contributed more than 6,100 volunteer hours in communities across Canada to make a meaningful difference.
As part of Baxter’s annual campaign to support the United Way, employees raised nearly $200,000 and earned a 2009 Spirit Award, Chair’s Award of Merit, from the United Way of Peel Region, and was named a Top 10 Campaign by the United Way of Simcoe County.